Arteriovenous malformations (AVMs) in or around the spinal cord can cause cord compression, ischemia, parenchymal hemorrhage, subarachnoid hemorrhage, or a combination. Symptoms may include gradually progressive, ascending, or waxing and waning segmental neurologic deficits; radicular pain; and sudden back pain with sudden segmental neurologic deficits. Diagnosis is by MRI. Treatment is with surgery or stereotactic radiosurgery and may include angiographic embolization.

AVMs are the most common spinal vascular malformations. Most are thoracolumbar, posterior, and outside the cord (extramedullary). The rest are cervical or upper thoracic and often inside the cord (intramedullary). AVMs may be small and localized or may affect up to half the cord. They may compress or even replace normal spinal cord parenchyma, or they may rupture, causing focal or generalized hemorrhage.

Diagnosis

Imaging

Spinal cord AVMs may be detected incidentally during imaging. AVMs are suspected clinically in patients with unexplained segmental neurologic deficits or subarachnoid hemorrhage, particularly those who have sudden, severe back pain or cutaneous midline angiomas.

Diagnosis of AVMs is by MRI (usually done first), then magnetic resonance angiography, and then selective arteriography. Occasionally, myelography plus CT is used.

Treatment

Surgery if spinal cord function is threatened

Surgery is indicated if spinal cord function is threatened, but expertise in specialized microtechniques is required. Stereotactic radiosurgery is helpful if the AVM is small and located in a surgically inaccessible location. Angiographic embolization occludes feeder arteries and often precedes surgical removal or stereotactic radiosurgery.

Was This Page Helpful?

Also of Interest

Test your
knowledge

Craniocervical junction abnormalities can be congenital or acquired. Acquired causes include injuries and disorders. Which of the following disorders is the most common cause of acquired craniocervical junction abnormalities?

MSD and the MSD Manuals

Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside of the US and Canada) is a global healthcare leader working to help the world be well. From developing new therapies that treat and prevent disease to helping people in need, we are committed to improving health and well-being around the world. The Manual was first published in 1899 as a service to the community. The legacy of this great resource continues as the Merck Manual in the US and Canada and the MSD Manual outside of North America. Learn more about our commitment to Global Medical Knowledge.